Clinical Trials · NCT00527488
Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia.
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 52
- Start date
- Oct 2007
- Locations
- 1 site, Germany
- Primary endpoint
- Testosterone Area Below Baseline Interval